How many drugs treat Vitamin deficiency?

Drug Landscape tracks 10 marketed treatments for Vitamin deficiency (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/vitamin-deficiency.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Vitamin deficiency — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vitamin deficiency (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Vitamin deficiency, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Infuvite Adult	Colecalciferol	Novartis	Vitamin D	Vitamin D3 receptor	2000-01-01
Thiamine Hydrochloride	THIAMINE	Pfizer	thiamine (vit B1)	Heat shock protein HSP 90-alpha	1993-01-01
Cyanocobalamin Co 57	cyanocobalamin (57Co)	Mallinckrodt	Radioactive Diagnostic Agent	Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial, Methionine synthase, Methionine synthase reductase	1968-01-01
Nicotinic Acid	NIACIN	MEDPOINTE PHARM HLC	Vitamin C [EPC]	NAD synthase	1957-01-01
Niaspan	Nicotinic Acid	Medpointe Pharm Hlc	Non-Standardized Food Allergenic Extract [EPC]	Hydroxycarboxylic acid receptor 2	1957-01-01
Infuvite Pediatric	RIBOFLAVIN	Glaukos	Vitamin C [EPC]	Flavin reductase (NADPH)	1953-01-01
M.V.I. Pediatric	RETINOL	Pfizer	Vitamin A	Amyloid beta A4 protein	1953-01-01
Folic Acid	FOLIC ACID	Pfizer	Vitamin C [EPC]	Thymidylate synthase	1946-01-01
FERROUS SULFATE	FERROUS SULFATE	Pfizer	ferrous sulfate		1946-01-01
Drisdol	ERGOCALCIFEROL	Esjay Pharma	Provitamin D2 Compound [EPC]	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	1941-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer · 4 drugs in Vitamin deficiency
· 2 drugs in Vitamin deficiency
Department of Medical Services Ministry of Public Health of Thailand · 1 drug in Vitamin deficiency
Esjay Pharma · 1 drug in Vitamin deficiency
Glaukos · 1 drug in Vitamin deficiency
Hospital Sao Domingos · 1 drug in Vitamin deficiency
MEDPOINTE PHARM HLC · 1 drug in Vitamin deficiency
Mallinckrodt · 1 drug in Vitamin deficiency
Medpointe Pharm Hlc · 1 drug in Vitamin deficiency
Novartis · 1 drug in Vitamin deficiency
Cedars-Sinai Medical Center · 1 drug in Vitamin deficiency

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Vitamin deficiency:

Cite this brief

Drug Landscape (2026). Vitamin deficiency — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/vitamin-deficiency. Accessed 2026-06-10.

Vitamin deficiency full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing